Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases
- 19 December 2020
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 164, 105384
- https://doi.org/10.1016/j.phrs.2020.105384
Abstract
No abstract availableKeywords
Funding Information
- National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology
- National Natural Science Foundation of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- Beijing Nova Program
This publication has 60 references indexed in Scilit:
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in MiceGastroenterology, 2012
- Critical role for calcium mobilization in activation of the NLRP3 inflammasomeProceedings of the National Academy of Sciences of the United States of America, 2012
- Sensing and reacting to microbes through the inflammasomesNature Immunology, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxideBioorganic & Medicinal Chemistry Letters, 2011
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the InflammasomeJournal of Biological Chemistry, 2010
- Mitochondrial calcium and the permeability transition in cell deathBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- SR/ER–mitochondrial local communication: Calcium and ROSBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- The NALP3 inflammasome is involved in the innate immune response to amyloid-βNature Immunology, 2008